Wednesday 8 November 2017

AMNEAL PHARMACEUTICALS WALK IN INTERVIEW ON 12/11/2017 @ AHMEDABAD



Walk-In Interview @ Amneal, Ahmedabad on 12th November, 2017 (Sunday)

We have multiple vacancies for our (OSD & Injectable) unit for our Ahmedabad SEZ Matoda & Rajoda Plant and for that we have arranged Walk-in Interview on Sunday, 12th November at below address:

Date: 12th November, Sunday

Timing: 9:00 AM to 2:00 PM

Venue:

Amneal Pharmaceuticals Pvt. Ltd.

5th Floor, 508-514

Venus Atlantis Corporate Park,

Above Gwalia Sweets, near Prahladnagar Garden

Prahladnagar, Ahmedabad

Landmark: Shell Petrol Pump

Please find the details of openings for our various departments:

1. Production / Manufacturing - Solid Oral/Tablet Capsules

Qualification: ITI / B. Pharm only

Designation: Operator / Officer / Executives

Experience: 2 -- 8 Yrs

Desired Profile:

- Candidate should have experience of CVC line, granulation, compression, coating, blister packing, bulk packing, capsulation etc

- Candidate must have exposure of Solid Oral Dosage Form.

- Please do not apply if you are from API and other than pharma background

2. Quality Control (QC OSD)

Designation: Officer/Sr. Officer/Executive/Sr. Executive

Qualification: B.Sc / M.Sc / B.Pharm / M.Pharm

Experience: 2-04 years

Desired Profile:

- Experience for the review of analytical data (both analytical raw data and electronic mete data) as per current requirements.

- Should have experience of LIMS software

- Experience to perform analysis of Raw-materials, In-process and Finished products, stability & validation samples.

- Should have experience to perform analytical method transfer/verification activity/ cleaning validation

- Should have experience to perform the investigation for Quality issues like Quality Incident, OOS, OOAL and Deviations during laboratory activities

Exposure to operate and perform the calibration/verification of laboratory instruments like Balance, pH meter, HPLC, UPLC, Dissolution, IR, KF, Auto Titrator, HPTLC and other sophisticated instruments in Quality control department

Exposure to perform working standard qualification etc

3. Analytical Research & Development (ARD/ADL- OSD)

Designation: Officer / Sr. Officer / Executive / Sr. Executive

Qualification: M.Sc (Analytical Chemistry) / B.Pharm / M.Pharm

Experience: 02 to 08 years

Desired Profile:

- Openings are for various groups in ARD like Exploratory, Method development, Raw Material Analysis, Routine & in process sample analysis, Stability group, Release group, Validation and Regulatory documentation group, GLP,LIMS etc.

4. Quality Assurance (QMS) (Parenteral)

Designation: For Executive / Sr. Executive /Assistance Manager

Qualification: B.Pharm / M.Pharm

Experience: 2 to 8 years

Desired Profile:

- Work experience in parenteral related QMS activities

Drafting of Deviation

Handling of CAPA

Handling Change control

Handing of Quality Risk Assessment documents

5. ARD Injectable

Designation: For Executive / Sr. Executive /Assistance Manager

Qualification: B.Pharm / M.Pharm Desired Profile :

Experience: 2 to 6 years

Desired Profile:

- To Perform and review method validation of Assay, Dissolution, Related compound and Residual solvents etc.

- To have experience to handle instruments like HPLC, IC and GC etc.

Having exposure of GLP, Method Transfer, ADL Documentation, Instrument calibration

6. Sterile Manufacturing:

Designation: Officer/ Operators

Qualification: B.Pharm / ITI only

Experience: 2 - 8 years

Desired Profile:

- Candidate should have experience of Vial washing, Lyophillization, compounding, Visual inspection, aseptic, sealing, filling, capping, Production compliance etc

Please carry 02 copies of your CV along with CTC proof and 2 passport size photograph.

You may refer this mail to your friends.

If you are unable to attend interview you can share CV onchandanid@amnealindia.com  &manojm@amnealindia.com

Regards,

Team HR

For more updates follow srinivasulutirumalasetty.blogspot.com
                  

Thank you for visiting my blog , Visit again for latest pharma updates

No comments:

Post a Comment